Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort

被引:3
作者
Van Deutekom, Colinda [1 ]
Geelhoed, Bastiaan [1 ]
Van Munster, Barbara C. [2 ]
Bakker, Stephan J. L. [3 ]
Gansevoort, Ron T. [3 ]
Van Gelder, Isabelle C. [1 ]
Rienstra, Michiel [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
来源
OPEN HEART | 2023年 / 10卷 / 02期
基金
欧盟地平线“2020”;
关键词
Atrial Fibrillation; EPIDEMIOLOGY; RISK FACTORS; HEART-FAILURE; POPULATION; MORTALITY; OUTCOMES;
D O I
10.1136/openhrt-2023-002315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveAtrial fibrillation (AF) is a condition that occurs in the presence of comorbidities. With the accumulation of comorbidities (multimorbidity), some combinations may more often occur together than others. Information on the impact of clustering of these on incident AF is sparse. We aimed to investigate clustering of cardiovascular and renal comorbidities and study the association between comorbidity clusters and incident AF. MethodsWe used the community-based Prevention of Renal and Vascular ENd-stage Disease (PREVEND) cohort in which 8592 individuals participated. Latent class analysis was performed to assess clustering of 10 cardiovascular and renal comorbidities. ResultsWe excluded individuals with prior AF or missing ECG data, leaving 8265 individuals for analysis (mean age 48.9 & PLUSMN;12.6 years, 50.2% women). During 9.2 & PLUSMN;2.1 years of follow-up, 251 individuals (3.0%) developed AF. A model with three clusters was the optimal model, with one cluster being young (44.5 & PLUSMN;10.8 years) and healthy, carrying a low (1.0%) risk of incident AF; one cluster being older (63.0 & PLUSMN;8.4 years) and multimorbid, carrying a high (16.2%) risk of incident AF and a third middle-aged (57.0 & PLUSMN;11.3 years), obese and hypertensive cluster carrying an intermediate risk (5.9%) of incident AF. While the prevalence of the comorbidities differed between classes, no clear combination(s) of comorbidities was observed within the classes. ConclusionsWe identified three clusters of comorbidities in individuals in the community-based PREVEND cohort. The three clusters contained different amount of comorbidities carrying different risks of incident AF. However, there were no differences between the clusters regarding specific combination(s) of comorbidities.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Atrial Fibrillation Ablation: Impact on Burden and Cardiovascular Outcomes
    AlTurki, Ahmed
    Essebag, Vidal
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (08)
  • [42] Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study
    Karasoy, Deniz
    Jensen, Thomas Bo
    Hansen, Morten Lock
    Schmiegelow, Michelle
    Lamberts, Morten
    Gislason, Gunnar Hilmar
    Hansen, Jim
    Torp-Pedersen, Christian
    Olesen, Jonas Bjerring
    EUROPACE, 2013, 15 (06): : 781 - 786
  • [43] Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study
    Molto-Balado, P.
    Reverte-Villarroya, S.
    Monclus-Arasa, C.
    Balado-Albiol, M. T.
    Baset-Martinez, S.
    Carot-Domenech, J.
    Clua-Espuny, J. L.
    BIOMEDICINES, 2023, 11 (07)
  • [44] Association between cardiovascular risk factors and atrial fibrillation
    Wu, Guohao
    Wu, Jingguo
    Lu, Qin
    Cheng, Yunjiu
    Mei, Weiyi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [45] β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases
    Gu, Xun-Hu
    Li, Weichao
    Li, Heng
    Guo, Xun
    He, Jiang
    Liu, Yuyan
    Gong, Jianping
    Huang, Yizhou
    Zhang, Bin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [46] Relationship between multimorbidity and outcomes in atrial fibrillation
    Proietti, Marco
    Esteve-Pastor, Maria Asuncion
    Rivera-Caravaca, Jose Miguel
    Roldan, Vanessa
    Rabadan, Inmaculada Roldan
    Muniz, Javier
    Cequier, Angel
    Bertomeu-Martinez, Vicente
    Badimon, Lina
    Anguita, Manuel
    Lip, Gregory Y. H.
    Marin, Francisco
    EXPERIMENTAL GERONTOLOGY, 2021, 153
  • [47] Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study
    Gue, Ying X.
    Bisson, Arnaud
    Bodin, Alexandre
    Herbert, Julien
    Lip, Gregory Y. H.
    Fauchier, Laurent
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (12)
  • [48] Atrial Fibrillation and Risk of Dementia: A Prospective Cohort Study
    Dublin, Sascha
    Anderson, Melissa L.
    Haneuse, Sebastien J.
    Heckbert, Susan R.
    Crane, Paul K.
    Breitner, John C. S.
    McCormick, Wayne
    Bowen, James D.
    Teri, Linda
    McCurry, Susan M.
    Larson, Eric B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (08) : 1369 - 1375
  • [49] Cardiovascular & renal - Pharmacological therapy of atrial fibrillation
    Patton, Kristen K.
    Page, Richard L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 169 - 179
  • [50] Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation
    Smith, J. Gustav
    Newton-Cheh, Christopher
    Almgren, Peter
    Struck, Joachim
    Morgenthaler, Nils G.
    Bergmann, Andreas
    Platonov, Pyotr G.
    Hedblad, Bo
    Engstroem, Gunnar
    Wang, Thomas J.
    Melander, Olle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (21) : 1713 - 1719